Illumina has invested in six genomics start-ups for the fifth global funding cycle of its Illumina Accelerator in the San Francisco Bay area and in Cambridge, via the DNA sequencing and array-based technologies company’s Granta Park base.
Illumina has invested in six genomics start-ups for the fifth global funding cycle of its Illumina Accelerator in the San Francisco Bay area and in Cambridge, via the DNA sequencing and array-based technologies company’s Granta Park base.